116
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study

ORCID Icon, , , , , , , , , , ORCID Icon & show all
Pages 2053-2061 | Published online: 30 Jun 2020

References

  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.028726903338
  • Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–1174. doi:10.1097/CCM.0b013e31827c09f823442987
  • Suarez De La Rica A, Gilsanz F, Maseda E. Epidemiologic trends of sepsis in western countries. Ann Transl Med. 2016;4(17):325. doi:10.21037/atm.2016.08.5927713883
  • Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594–2605. doi:10.1001/jama.2011.182922187279
  • Mira JC, Gentile LF, Mathias BJ, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;45(2):253–262. doi:10.1097/CCM.000000000000207427632674
  • Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862–874. doi:10.1038/nri355224232462
  • Gouel-Cheron A, Allaouchiche B, Floccard B, Rimmele T, Monneret G. Early daily mHLA-DR monitoring predicts forthcoming sepsis in severe trauma patients. Intensive Care Med. 2015;41(12):2229–2230. doi:10.1007/s00134-015-4045-126359166
  • Wu JF, Ma J, Chen J, et al. Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis. Crit Care. 2011;15(5):R220. doi:10.1186/cc1045721933399
  • Landelle C, Lepape A, Voirin N, et al. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med. 2010;36(11):1859–1866. doi:10.1007/s00134-010-1962-x20652682
  • Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006;32(8):1175–1183. doi:10.1007/s00134-006-0204-816741700
  • Lin HY, Guo XS, Yao YM, et al. Clinical trial to verify the value of the CD14(+) monocyte human leukocyte antigen DR as a marker in evaluating immunosuppression in patients with severe sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003;15(3):135–138.12831612
  • Meisel C, Schefold JC, Pschowski R, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med. 2009;180(7):640–648. doi:10.1164/rccm.200903-0363OC19590022
  • Caruso C, Buffa S, Candore G, et al. Mechanisms of immunosenescence. Immun Ageing. 2009;6(1):10. doi:10.1186/1742-4933-6-1019624841
  • Martin S, Perez A, Aldecoa C. Sepsis and immunosenescence in the elderly patient: a review. Front Med (Lausanne). 2017;4:20. doi:10.3389/fmed.2017.0012928293557
  • Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):1244–1250. doi:10.1097/01.CCM.0000261890.41311.E917414736
  • Baykara N, Akalin H, Arslantas MK, et al. Epidemiology of sepsis in intensive care units in Turkey: a multicenter, point-prevalence study. Crit Care. 2018;22(1):93. doi:10.1186/s13054-018-2013-129656714
  • Lee SH, Hsu TC, Lee MG, et al. Nationwide trend of sepsis: a comparison among octogenarians, elderly, and young adults. Crit Care Med. 2018;46(6):926–934. doi:10.1097/CCM.000000000000308529533311
  • Inoue S, Suzuki-Utsunomiya K, Okada Y, et al. Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit Care Med. 2013;41(3):810–819. doi:10.1097/CCM.0b013e318274645f23328259
  • Suzuki K, Inoue S, Kametani Y, et al. Reduced immunocompetent B cells and increased secondary infection in elderly patients with severe sepsis. Shock. 2016;46(3):270–278. doi:10.1097/SHK.000000000000061927172158
  • Muszynski JA, Nofziger R, Moore-Clingenpeel M, et al. Early immune function and duration of organ dysfunction in critically iii children with sepsis. Am J Respir Crit Care Med. 2018;198(3):361–369. doi:10.1164/rccm.201710-2006OC29470918
  • Wu J, Zhou L, Liu J, et al. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Crit Care. 2013;17(1):R8. doi:10.1186/cc1193223327199
  • World Health Organization. China country assessment report on ageing and health. 2015 Available from: http://www.who.int/ageing/publications/china-country-assessment/en/. Accessed 1013, 2019..
  • Pfortmueller CA, Meisel C, Fux M, Schefold JC. Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers. Intensive Care Med Exp. 2017;5(1):49. doi:10.1186/s40635-017-0163-029063386
  • Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation–rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996;22(Suppl 4):S474–S481. doi:10.1007/BF17437278923092
  • Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754–1758. doi:10.1001/jama.286.14.175411594901
  • Remy S, Kolev-Descamps K, Gossez M, et al. Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study. Ann Intensive Care. 2018;8(1):36. doi:10.1186/s13613-018-0382-x29536210
  • Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13(3):260–268. doi:10.1016/S1473-3099(13)70001-X23427891
  • Biston P, Aldecoa C, Devriendt J, et al. Outcome of elderly patients with circulatory failure. Intensive Care Med. 2014;40(1):50–56. doi:10.1007/s00134-013-3121-724132383
  • Flaatten H, de Lange DW, Artigas A, et al. The status of intensive care medicine research and a future agenda for very old patients in the ICU. Intensive Care Med. 2017;43(9):1319–1328. doi:10.1007/s00134-017-4718-z28238055
  • Lukaszewicz AC, Grienay M, Resche-Rigon M, et al. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med. 2009;37(10):2746–2752. doi:10.1097/CCM.0b013e3181ab858a19707128
  • Perry SE, Mostafa SM, Wenstone R, Shenkin A, McLaughlin PJ. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis? Intensive Care Med. 2003;29(8):1245–1252. doi:10.1007/s00134-003-1686-212774155